A New Concise Strategy for Synthesis of
Dibenzo[b,f]thiepins and Related Fused
Symmetrical Thiepin Derivatives
Hamid Shirani and Tomasz Janosik*
Unit for Organic Chemistry, Department of Biosciences and
Nutrition, Karolinska Institute, NoVum Research Park, SE-141
FIGURE 1. Structures of the parent dibenzo[b,f]thiepin (1) and some
biologically active derivatives (2 and 3).
5
7 Huddinge, Sweden
5
thioxanthene p-toluenesulfonate, Friedel-Crafts-type cycliza-
tion of 2-(2-arythiophenyl)acetic acids, followed by further
elaboration of the resulting 10,11-dihydrodibenzo[b,f]thiepin-
0-one derivatives, or treatment of bis(aryl) sulfides with
chloroacetyl chloride in the presence of AlCl3.
ReceiVed July 25, 2007
6
1
7
Since the existing routes to dibenzo[b,f]thiepins either require
preparation of elaborate starting materials, or proceed in low
overall yields, we embarked upon development of an alternative
concise approach starting from readily available 2-bromoben-
zaldehyde acetals. It is well-established that treatment of
metalated aromatics or heteroaromatics with bis(phenylsulfonyl)
8
9
sulfide provides good yields of bis(aryl) sulfides or bis-
(
8
,10
heteroaryl) sulfides,
respectively. Hence, it was envisaged
A new strategy for preparation of dibenzo[b,f]thiepins and
related fused systems in good overall yields is described,
featuring ortho-metalation of aromatic or heterocyclic alde-
hyde acetals followed by treatment with bis(phenylsulfonyl)
sulfide for construction of the required bis(aryl)- or bis-
that utilization of lithiated benzenes incorporating masked
1
1
reactive functional groups ortho to the metal in a similar
fashion may give bis(aryl) sulfide intermediates suitable for
synthesis of new fused thiepin derivatives. Accordingly, the
1
2
13
benzaldehyde acetals 4 and 5 were subjected to halogen-
lithium exchange, followed by treatment of the resulting
organolithium species with bis(phenylsulfonyl) sulfide to afford
the desired bis(aryl) sulfides 6 and 7 (Scheme 1). These
compounds were thereafter subjected to acid induced deacetal-
(heteroaryl) sulfide precursors, which were thereafter sub-
jected to deacetalization, and finally McMurry coupling as
the ring-forming step.
1
4
ization providing the known dialdehyde 8 and its derivative
9, which served as substrates in intramolecular McMurry
1
The thiepins, including the condensed ring system dibenzo-
1
c
15
[
b,f]thiepin (1), have attracted considerable attention over the
coupling reactions, eventually giving the known parent diben-
5
years, for instance, in connection with theoretical studies
concerning aromaticity. More importantly, it has also been
demonstrated that several dibenzo[b,f]thiepin derivatives display
potent biological activities, as illustrated, for example, by the
molecule zotepine (2), which has psychosedative and antipsy-
zo[b,f]thiepin (1), as well as the electron-rich substituted system
10.
(
5) Bergmann, E. D.; Rabinovitz, M. J. Org. Chem. 1960, 25, 828-
829.
(6) See for example: Protiva, M.; Sˇ ediv y´ , Z.; Pomyk a´ cˇ ek, J.; Sv a´ tek,
E.; Holubek, J. Collect. Czech. Chem. Commun. 1981, 46, 1199-1209.
7) J ´ı lek, J.; Pomyk a´ cˇ ek, J.; Holubek, J.; Sv a´ tek, E.; Ryska, M.; Protiva,
2
3
chotic properties, or the prostaglandin antagonist 3 (Figure 1).
A series of compounds based on this ring system has also been
(
4
evaluated for antiestrogenic affects. The interest for dibenzo-
M.; Protiva, M. Collect. Czech. Chem. Commun. 1984, 49, 603-620.
[b,f]thiepins in pharmacological applications has exerted con-
(8) De Jong, F.; Janssen, M. J. J. Org. Chem. 1971, 36, 1645-1648.
(9) See, for example: (a) Yamazaki, D.; Nishinaga T.; Komatsu, K. Org.
siderable impact on the development of their chemistry, resulting
in hundreds of papers and patents.1 However, despite the
numerous publications on the subject, there are only a few
synthetic routes to dibenzo[b,f]thiepin derivatives available,
namely acid-induced rearrangement of 9-(hydroxymethyl)-
Lett. 2004, 6, 4179-4182. (b) D o¨ tze, M.; Klar, G. Phosphorus Sulfur Silicon
c
1
993, 84, 95-106.
(10) For some recent examples, see: (a) Rajca, A.; Wang, H.; Pink, M.;
Rajca, S. Angew. Chem., Int. Ed. 2000, 39, 4481-4483. (b) Miyasaka, M.;
Rajca, A.; Pink, M.; Rajca, S. J. Am. Chem. Soc. 2005, 127, 13806-13807.
(
c) Miyasaka, M.; Rajca, A. J. Org. Chem. 2006, 71, 3264-3266. (d)
Shirani, H.; Stensland, B.; Bergman J.; Janosik, T. Synlett 2006, 2459-
2463.
(
1) For reviews, see: (a) Yamamoto, K.; Yamazaki, S. In ComprehensiVe
Heterocyclic Chemistry II; Katritzky, A. R., Rees C. W., Scriven, E. F. V.,
Eds.; Elsevier: Amsterdam, 1996; Vol. 9, pp 67-111. (b) Schwan, A. L.
In Science of Synthesis; Weinreb, S. M., Ed.; Thieme: Stuttgart, 2004; Vol.
(11) For reviews, see: (a) Snieckus, V. Chem. ReV. 1990, 90, 879-933.
(b) Schlosser, M. Angew. Chem., Int. Ed. 2005, 44, 376-393.
(12) (a) Watanabe, T.; Soma, N. Chem. Pharm. Bull. 1971, 19, 2215-
2221. (b) Newman, M. S.; Lee, L.-F. J. Org. Chem. 1975, 40, 2650-2652.
(13) Charlton, J. L.; Alauddin, M. M. J. Org. Chem. 1986, 51, 3490-
3493.
(14) (a) Jiang, J.-J.; Chang, T.-C.; Hsu, W.; Hwang, J.-M.; Hsu, L.-Y.
Chem. Pharm. Bull. 2003, 51, 1307-1310. (b) Britovsek, G. J. P.; Gibson,
V. C.; Hoarau, O. D.; Spitzmesser, S. K.; White, A. J. P.; Williams, D. J.
Inorg. Chem. 2003, 42, 3454-3465.
1
7, pp 717-748. (c) Protiva, M. J. Heterocycl. Chem. 1996, 33, 497-521.
2) Ueda, I.; Sato, Y.; Maeno, S.; Umio, S. Chem. Pharm. Bull. 1978,
6, 3058-3070.
3) (a) U.S. Patent 4237160, 1980; Chem. Abstr. 1981, 94, 208728. (b)
(
2
(
Hands, D.; Marley, H.; Skittrall, S. J.; Wright, S. H. B.; Verhoeven, T. R.
J. Heterocycl. Chem. 1986, 23, 1333-1337.
(4) Acton, D.; Hill, G.; Tait, B. S. J. Med. Chem. 1983, 26, 1131-1137.
10.1021/jo701627g CCC: $37.00 © 2007 American Chemical Society
8
984
J. Org. Chem. 2007, 72, 8984-8986
Published on Web 10/12/2007